Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.
about
Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@ast
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@en
type
label
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@ast
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@en
prefLabel
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@ast
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@en
P2093
P2860
P1433
P1476
Impact of hormone receptor sta ...... tive metastatic breast cancer.
@en
P2093
Gen-Hong Di
Hai-Yuan Yang
Jian Zhang
Xi-Chun Hu
Yi-Rong Liu
Zhi-Ming Shao
Zhong-Hua Wang
P2860
P2888
P356
10.1038/S41598-017-00663-1
P407
P577
2017-04-25T00:00:00Z
P6179
1085053858